Provided by Tiger Trade Technology Pte. Ltd.

ArTara Therapeutics, Inc.

3.85
-0.0500-1.28%
Pre-market: 3.900.0500+1.30%04:39 EDT
Volume:238.40K
Turnover:921.28K
Market Cap:227.52M
PE:-2.84
High:3.95
Open:3.91
Low:3.81
Close:3.90
52wk High:7.82
52wk Low:3.02
Shares:59.10M
Float Shares:57.41M
Volume Ratio:0.72
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3535
EPS(LYR):-1.3409
ROE:-45.80%
ROA:-28.82%
PB:1.41
PE(LYR):-2.87

Loading ...

Unusually active option classes on open May 15th

TIPRANKS
·
May 15

Protara announces updated 12-month data from Cohort A of ADVANCED-2 trial

TIPRANKS
·
May 15

Protara says TARA-002 posts 55% 12-month complete response in ADVANCED-2 trial

Reuters
·
May 15

Protara Therapeutics Inc: on Track to Initiate Advanced-3 Registrational Trial in Bcg-NaÏVe Patients in 2H 2026

THOMSON REUTERS
·
May 15

Protara Therapeutics Inc: Tara-002 Demonstrates 55% Complete Response Rate at 12-Month Landmark

THOMSON REUTERS
·
May 15

Protara Therapeutics Inc: Tara-002 Showed Favorable Safety and Tolerability Profile

THOMSON REUTERS
·
May 15

Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled Bcg-NaÏVe Cohort of the Ongoing Phase 2 Advanced-2 Trial of Tara-002 in Nmibc

THOMSON REUTERS
·
May 15

Protara Therapeutics Inc - May Offer up to $300 Mln of Securities - SEC Filing

THOMSON REUTERS
·
May 14

Analysts Are Bullish on These Healthcare Stocks: Abeona Therapeutics (ABEO), Protara Therapeutics (TARA)

TIPRANKS
·
May 14

Protara Therapeutics Q1 net loss widens on higher expenses

Reuters
·
May 13

Protara Therapeutics Q1 EPS USD -0.31

THOMSON REUTERS
·
May 13

CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

GlobeNewswire
·
May 01

Protara Therapeutics Inc : H.c. Wainwright Raises Target Price to $27 From $23

THOMSON REUTERS
·
Apr 29

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Protara Therapeutics (TARA)

TIPRANKS
·
Apr 29

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

GlobeNewswire
·
Apr 28

Protara Therapeutics to Present Updated, Interim 12-Month Data From the Phase 2 Advanced-2 Trial of Tara-002 in Bcg-NaÏVe Nmibc Patients at the American Urological Association Annual Meeting

THOMSON REUTERS
·
Apr 28

Press Release: Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting

Dow Jones
·
Apr 28

Protara Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 18

Bayer’s TARA Study: Real‑World Prostate Cancer Data That Could Shape BAYRY’s Outlook

TIPRANKS
·
Apr 17

Protara Chief R&D Officer Jacqueline Zummo sells USD 6,124 common shares

Reuters
·
Apr 10